Acadia pharmaceuticals to participate in the guggenheim securities 5th annual inflammation & immunology conference

San diego--(business wire)--acadia pharmaceuticals inc. (nasdaq: acad) today announced that it will participate in the guggenheim securities 5th annual inflammation & immunology (i&i) conference on tuesday, november 7, 2023 at 4:30 p.m. eastern time. a live webcast of the presentation will be accessible on the company's website, www.acadia.com, under the investors section and an archived recording will be available on the website for approximately one month following the presentation. a.
ACAD Ratings Summary
ACAD Quant Ranking